TÜSİAD Silicon Valley Network will examine the relationship between artificial intelligence and biotechnology in the third event it will organize within the scope of the “Artificial Intelligence Webinar Series”. At the event titled “Artificial Intelligence & Biotechnology: Accelerating Innovation from the Laboratory to People”, which will take place online on May 8, the effects of rapidly developing artificial intelligence technology on the biotechnology industry and the future of these two fields will be discussed from different perspectives.
At the event, important issues such as the impact of artificial intelligence on investment trends in the biotechnology industry, its use in pre-clinical and clinical research, and its potential to accelerate drug research and production will be discussed.
Experts in their fields such as SiteAI Founder and CEO Özgü Tokgöz, Ernst & Young Health Industry Leader and Partner Arda Ural, Massive Bio Founder and CEO Selin Kurnaz and Genentech Artificial Intelligence Researcher Gökçen Erarslan will be speakers.
TÜSİAD Silicon Valley Network President Ayşegül İldeniz will give the opening speech and the moderator of the event will be Headland Strategy Group Consultant Bora Güner. Those who want to participate in the event, which will be held in Turkish, can register via the provided link.
It is an event not to be missed for those who want to closely follow the developments in the field of artificial intelligence and biotechnology and learn about the future cooperation potential of these two fields.
- To watch the event from the link You can register.
- The participation link will be sent to your e-mail address on the day of the event.